Therefore, we assessed the expression of VEGF-C and VEGFR-3 mRNA in NSCLC by real-time quantitative RT–PCR to demonstrate how they correlated with clinicopathological factors, including lymph node metastasis. The gene discussed is FLT4; the disease is non-small cell lung carcinoma.